RDHL – RedHill Biopharma Phase 3 Top Line Data RHB-104

When:
August 1, 2018 @ 6:33 pm – August 15, 2018 @ 7:33 pm
2018-08-01T18:33:00-04:00
2018-08-15T19:33:00-04:00

RDHL – RedHill Biopharma, should be announcing Phase 3 Top Line Data on it’s RHB-104 for Crohn’s disease sometime in Early August 2018.

RDHL SEC Filings : http://ir.redhillbio.com/financial-information

Would have been nice to have gotten in RDHL at $8, but could have a move over $10 (possible mid $10’s or $11) if it gets moving into the catalyst.